ZoomInfo Grew Revenue Just 1.5% as This Fund Sold $17 Million in Shares Last Quarter

Cramer Rosenthal McGlynn sold 2,427,818 ZoomInfo Technologies shares in Q1, an estimated $17.85 million trade, leaving the fund with 889,757 shares valued at $5.32 million. The fund’s position value fell $28.42 million overall, reflecting both the sale and the stock’s sharp decline. ZoomInfo remains under pressure with shares down more than 60% over the past year, though the company still generated $114.7 million of operating cash flow and repurchased $90.5 million of stock.

Analysis

The meaningful signal here is not the headline reduction itself, but that a long-only manager appears to be voting with position size against a stock that is already priced like a business in structural decline. That matters because GTM’s shareholder base is likely increasingly dominated by benchmark-aware value and event-driven holders rather than conviction growth capital, which can amplify downside on any disappointment and reduce the stock’s ability to re-rate on incremental good news. In that regime, buybacks can cushion per-share metrics, but they do little to fix the core issue: the market wants reacceleration, not efficiency.

The second-order effect is competitive, not just company-specific. If GTM continues to monetize a shrinking customer cohort while maintaining strong cash generation, larger marketing/sales software peers and adjacent data platforms can use the vacuum to poach budget share with AI-native workflows. The underappreciated risk is that “good cash flow” becomes a value trap: the business can support repurchases for several quarters, but if net retention stays sub-100 and mid-market customer counts keep softening, buybacks merely finance a slower decline in enterprise relevance.

The catalyst path is asymmetric over the next 1-3 quarters: either product-led AI adoption shows up in durable customer adds and a stabilization in NRR, or the stock remains a multiple compression story regardless of earnings quality. In a low-expectation setup, the squeeze higher can be violent if management delivers even modest growth inflection, but absent that proof the path of least resistance remains lower. The consensus may be underestimating how much of the bull case is already dependent on a macro/software multiple rebound rather than fundamentals.

Key Decisions for Investors

• Short GTM on strength over the next 2-6 weeks; use rallies toward recent resistance as entry, with a tactical stop if management guides to sequential growth acceleration or NRR inflects above 95.
• Pair long NVDA / short GTM for 1-2 quarters: NVDA captures AI monetization directly, while GTM is a slower-lane software beneficiary whose AI narrative is still unproven; this isolates AI enthusiasm from execution risk.
• For event-driven accounts, sell cash-secured puts or run a defined-risk bullish put spread in GTM 1-3 months out only if implied vol stays elevated; the thesis is mean reversion off extremely depressed expectations, but keep downside capped because fundamental deterioration could persist.
• Avoid adding to long-only software exposure via GTM until the company shows at least two consecutive quarters of customer stabilization; the risk/reward is poor if the story remains buyback-supported rather than growth-led.